Trades on 4 secondary markets

Genesis Molecular AI

Genesis Therapeutics (Genesis Molecular AI) is an AI-focused biotechnology company building GEMS (Genesis Exploration of Molecular Space), a generative and predictive AI operating system for small-molecule drug discovery. GEMS combines structure-based deep learning, language and diffusion models, an

minimal 7.7 / 100 0 APIs View provider profile →

Company Artificial Intelligence Machine Learning Drug Discovery Biotechnology Life Sciences

Genesis Molecular AI is an API provider whose private shares are listed on 4 secondary markets: Forge Global, Hiive, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.